These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2447510

  • 1. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
    Pulay T, Csömör S, Mészáros K, Szarka G, Csabay L, Szinnyai A.
    Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
    [Abstract] [Full Text] [Related]

  • 2. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
    Tottori K, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL, Purnell DM, Combs JW, Hillman EA, Harris CC, Trump BF.
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [Abstract] [Full Text] [Related]

  • 4. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
    Obata N, Kodama S, Hando T, Takeuchi S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
    [Abstract] [Full Text] [Related]

  • 5. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
    Yonemura Y, Oyama S, Sugiyama K, Sawa T, Shima Y, Kamata T, Hashimoto T, Miwa K, Miyazaki I.
    Int Surg; 1989 Jun; 74(2):84-7. PubMed ID: 2473961
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
    Takakura N, Mimura H, Hamazaki K, Kim H, Hirata K, Miwata H, Kimura T, Sakata T, Hosoba T, Orita K.
    Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary.
    Furumoto M.
    Pathol Res Pract; 1981 Dec; 173(1-2):12-21. PubMed ID: 6174958
    [Abstract] [Full Text] [Related]

  • 12. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R, Marinov B, Milkov V, Milanov S.
    Akush Ginekol (Sofiia); 1984 Dec; 23(4):315-20. PubMed ID: 6207743
    [No Abstract] [Full Text] [Related]

  • 13. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM, Shah NG, Trivedi SN, Karelia NH.
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Mar; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 15. Tumor markers for ovarian cancer.
    Bhattacharya M, Barlow JJ.
    Int Adv Surg Oncol; 1979 Mar; 2():155-76. PubMed ID: 95453
    [Abstract] [Full Text] [Related]

  • 16. The evaluation of tumor markers levels in determination of surgical procedure in patients with gallbladder carcinoma.
    Stefanović D, Novaković R, Perisić-Savić M, Djordjević Z, Zivanović M, Stajić S.
    Med Pregl; 1993 Mar; 46 Suppl 1():58-9. PubMed ID: 8569609
    [Abstract] [Full Text] [Related]

  • 17. Serum tumor markers.
    Perkins GL, Slater ED, Sanders GK, Prichard JG.
    Am Fam Physician; 2003 Sep 15; 68(6):1075-82. PubMed ID: 14524394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H, Kameyama S, Aso Y.
    Gan To Kagaku Ryoho; 1987 Nov 15; 14(11):3034-40. PubMed ID: 2445294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.